دورية أكاديمية

In vitro anti-plasmodial activity of Dicoma anomala subsp. gerrardii (Asteraceae): identification of its main active constituent, structure-activity relationship studies and gene expression profiling

التفاصيل البيبلوغرافية
العنوان: In vitro anti-plasmodial activity of Dicoma anomala subsp. gerrardii (Asteraceae): identification of its main active constituent, structure-activity relationship studies and gene expression profiling
المؤلفون: van Heerden Fanie R, Parkinson Chris, Mmutlane Edwin M, Crampton Bridget G, Pillay Pamisha, van Brummelen Anna C, van der Merwe Marina M, Becker John VW, Crouch Neil R, Smith Peter J, Mancama Dalu T, Maharaj Vinesh J
المصدر: Malaria Journal, Vol 10, Iss 1, p 295 (2011)
بيانات النشر: BMC, 2011.
سنة النشر: 2011
المجموعة: LCC:Arctic medicine. Tropical medicine
LCC:Infectious and parasitic diseases
مصطلحات موضوعية: Arctic medicine. Tropical medicine, RC955-962, Infectious and parasitic diseases, RC109-216
الوصف: Abstract Background Anti-malarial drug resistance threatens to undermine efforts to eliminate this deadly disease. The resulting omnipresent requirement for drugs with novel modes of action prompted a national consortium initiative to discover new anti-plasmodial agents from South African medicinal plants. One of the plants selected for investigation was Dicoma anomala subsp. gerrardii, based on its ethnomedicinal profile. Methods Standard phytochemical analysis techniques, including solvent-solvent extraction, thin-layer- and column chromatography, were used to isolate the main active constituent of Dicoma anomala subsp. gerrardii. The crystallized pure compound was identified using nuclear magnetic resonance spectroscopy, mass spectrometry and X-ray crystallography. The compound was tested in vitro on Plasmodium falciparum cultures using the parasite lactate dehydrogenase (pLDH) assay and was found to have anti-malarial activity. To determine the functional groups responsible for the activity, a small collection of synthetic analogues was generated - the aim being to vary features proposed as likely to be related to the anti-malarial activity and to quantify the effect of the modifications in vitro using the pLDH assay. The effects of the pure compound on the P. falciparum transcriptome were subsequently investigated by treating ring-stage parasites (alongside untreated controls), followed by oligonucleotide microarray- and data analysis. Results The main active constituent was identified as dehydrobrachylaenolide, a eudesmanolide-type sesquiterpene lactone. The compound demonstrated an in vitro IC50 of 1.865 μM against a chloroquine-sensitive strain (D10) of P. falciparum. Synthetic analogues of the compound confirmed an absolute requirement that the α-methylene lactone be present in the eudesmanolide before significant anti-malarial activity was observed. This feature is absent in the artemisinins and suggests a different mode of action. Microarray data analysis identified 572 unique genes that were differentially expressed as a result of the treatment and gene ontology analysis identified various biological processes and molecular functions that were significantly affected. Comparison of the dehydrobrachylaenolide treatment transcriptional dataset with a published artesunate (also a sesquiterpene lactone) dataset revealed little overlap. These results strengthen the notion that the isolated compound and the artemisinins have differentiated modes of action. Conclusions The novel mode of action of dehydrobrachylaenolide, detected during these studies, will play an ongoing role in advancing anti-plasmodial drug discovery efforts.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1475-2875
العلاقة: http://www.malariajournal.com/content/10/1/295Test; https://doaj.org/toc/1475-2875Test
DOI: 10.1186/1475-2875-10-295
الوصول الحر: https://doaj.org/article/0fa8d2723c2b4efca7f4120d482ce954Test
رقم الانضمام: edsdoj.0fa8d2723c2b4efca7f4120d482ce954
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14752875
DOI:10.1186/1475-2875-10-295